Publication | Closed Access

Oxyresveratrol ameliorates nonalcoholic fatty liver disease by regulating hepatic lipogenesis and fatty acid oxidation through liver kinase B1 and AMP-activated protein kinase

Metabolic SyndromeOxysterolHepatologyBiochemistryAmp-activated Protein KinaseLiver PhysiologyMedicinePathologyHepatic LipogenesisHepatotoxicityLiver DiseaseFatty Liver DiseasePharmacologyLiver Kinase B1Oxidative StressHealth Sciences